News AstraZeneca PLC Nasdaq

Equities

AZN

US0463531089

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
76.9 ^USD	-0.18%		-0.36%	+14.18%

May. 17	Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial	RE
May. 16	AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial	May. 17	RE
AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial	May. 16	MT
Global markets live: Cisco, EasyJet, Roche, Netflix, Amazon...	May. 16
AlzeCure Pharma AB - Eli Lilly's and AstraZeneca's former head of research Dr. Jan Lundberg elected as a new board member	May. 16	AQ
AstraZeneca : SUPERNOVA Phase III trial of sipavibart long-acting antibody met primary endpoints in preventing COVID-19 in immunocompromised patient population - Form 6-K	May. 16	PU
AstraZeneca trials yield positive results for immunocompromised patients	May. 16	AN
AstraZeneca: positive results in Covid prevention	May. 16	CF
Insights into AstraZeneca's MANDARA Phase III data	May. 16	AQ
The FTSE 100 is taking a breather	May. 16
AstraZeneca's Antibody Cuts COVID-19 Risk Among Immunocompromised in Late-stage Study	May. 16	MT
Notice to the Annual General Meeting of Cline Scientific AB	May. 16	AQ
AstraZeneca PLC Phase III Trial of Sipavibart Long-Acting Antibody Met Primary Endpoints in Preventing COVID-19 in Immunocompromised Patient Population	May. 16	CI
AstraZeneca : Transaction by Person Discharging Managerial Responsibilities - Form 6-K	May. 15	PU
ASTRAZENECA : UBS reiterates its Sell rating	May. 15	ZD
Eli Lilly’s and AstraZeneca’s former head of research Dr. Jan Lundberg elected as a new board member	May. 15	AQ
FDA extends review of Ascendis Pharma's hormone disorder therapy	May. 14	RE
ASTRAZENECA : Buy rating from JP Morgan	May. 14	ZD
AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study	May. 13	MT
AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study	May. 13	MT
AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study	May. 13	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 12:02 pm EDT